GL Capital Group has been investing in healthcare and healthcare only for 15 years, managing nearly USD 3.9 billion in healthcare assets. The firm has invested in 99 companies across diverse healthcare sub-sectors, such as pharmaceuticals, medical enterprises, healthcare services, in-vitro diagnostics (lVD), and contract research organizations (CROs), spanning the entire healthcare value chain, GL Capital partners with its portfolio companies to navigate challenges and seize opportunities in a continuously evolving industry and market, driving growth and value creation

CASE STUDIES

CASES

Maixin Biotech

MORE+

Fuzhou Maixin Biotech. Co., Ltd. is the most famous company of pathology in China. Focusing on immunohistochemistry for over 20 years, and having acquired most registration licenses from CFDA.The company was established in 1993 with its registered capital RMB 50 million, and has now more than 100 employees. The company mainly engage in production, research & development and sales and focus on tissue-based diagnostics specifically IHC antibodies, reagents and the automation of IHC and ISH.

SciClone Pharmaceuticals

MORE+

SciClone Pharmaceuticals (Holdings) Limited is an international biopharmaceutical company with an integrated platform for product development and commercialization. The company strategically focuses on some of the largest and fast-growing therapeutic areas with significant unmet medical needs in China, primarily including oncology and severe infection. Leveraging the integrated platform, the company strives to develop and commercialize a portfolio of high-quality marketed products.

Xihua

MORE+

Shanghai Xihua Scientific Co.,Ltd.(Xihua) was established in 2015. The headquarters is located in Pudong New District, Shanghai. We have subsidiaries Xihua Clinical , Suzhou Xihua, Xihua Pharmaceuticals, Chuzhou Xihua, etc. Besides, Xihua holds Primera Analytical Solutions Corp.(U.S.) and TCM Groups (U.S.) as well. Xihua provides global pharmaceutical companies with high quality and efficient full process and integrated services from self-medicated development to market approve.

Pharmaron

MORE+

Pharmaron (300759.SZ/3759.HK) is a premier service provider for the life sciences industry. Founded in 2004, Pharmaron has invested in its people and facilities and established a broad spectrum of research, development, and manufacturing service capabilities throughout the entire drug discovery, preclinical, and clinical development process across multiple therapeutic modalities. With over 21,000 employees and operations in China, the U.S.,and the U.K.

Foryou Medical

MORE+

Founded in 2005, Foryou Medical is an advanced wound care (AWC) CDMO (contract manufacturing and development organization) specializing in R&D, manufacturing and commercialization of advanced wound care dressings, polymeric hemostatic products and absorbable biomaterials. It serves the advanced wound care market with one of the most comprehensive product lines in the industry, backed by a strong technical team and R&D capabilities.

Xudong Haipu

MORE+

Shanghai Xudong Haipu Pharmaceutical Co., Ltd., originally known as Shanghai Haipu Pharmaceutical Factory, was established in 1925 and is the first injection factory in China. The company has nearly a century of history, accumulating extensive production experience and brand recognition.

Our Portfolio